Population
Diabetic cardiomyopathy
Design
Review
Authors
Loading...
Requires clinical caution with synthetic PPAR agonists in metabolic disease; leaves open mitochondrial targeting in diabetic cardiomyopathy.
This review highlights the complex and controversial role of PPAR agonists in modulating mitochondrial function in diabetic cardiomyopathy.
Lee et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: